Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (141-150 of 308) with videos related to

Pageof 31
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 19, 2019
Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleedingRahat A Abdoellakhan, Jan Beyer-Westendorf, Sam Schulman, et al.
Journal of Thrombosis and Thrombolysis|July 23, 2014
Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief reportLuca Masotti, Gianni Lorenzini, Cristiana Seravalle, et al.
Annals of Internal Medicine|December 7, 2007
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolismJames D Douketis, Chu Shu Gu, Sam Schulman, et al.
Journal of Thrombosis and Haemostasis : JTH|March 24, 2020
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysisEmanuele Valeriani, Ettore Porreca, Jeffrey I Weitz, et al.
Research and Practice in Thrombosis and Haemostasis|February 28, 2022
Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohortMatteo Candeloro, John W Eikelboom, Noel Chan, et al.
Journal of Internal Medicine|August 29, 2023
Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment-A nationwide register-based studyKatarina Glise Sandblad, Sam Schulman, Annika Rosengren, et al.
Thrombosis and Haemostasis|April 21, 2017
NOACs for treatment of venous thromboembolism in clinical practiceSam Schulman, Daniel Singer, Walter Ageno, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2019
Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issuesRahat A Abdoellakhan, Jan Beyer-Westendorf, Sam Schulman, et al.
Thrombosis and Haemostasis|December 23, 2016
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysisAmmar Majeed, Niklas Wallvik, Joakim Eriksson, et al.
Clinical Pharmacology and Therapeutics|May 21, 2005
Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosisMarie Cullberg, Ulf G Eriksson, Karin Wåhlander, et al.
Pageof 31

Showing results (141-150 of 308) with videos related to

Sort By:
Pageof 31
Journal of Thrombosis and Haemostasis : JTH|January 19, 2019
Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleedingRahat A Abdoellakhan, Jan Beyer-Westendorf, Sam Schulman, et al.
Journal of Thrombosis and Thrombolysis|July 23, 2014
Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief reportLuca Masotti, Gianni Lorenzini, Cristiana Seravalle, et al.
Annals of Internal Medicine|December 7, 2007
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolismJames D Douketis, Chu Shu Gu, Sam Schulman, et al.
Journal of Thrombosis and Haemostasis : JTH|March 24, 2020
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysisEmanuele Valeriani, Ettore Porreca, Jeffrey I Weitz, et al.
Research and Practice in Thrombosis and Haemostasis|February 28, 2022
Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohortMatteo Candeloro, John W Eikelboom, Noel Chan, et al.
Journal of Internal Medicine|August 29, 2023
Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment-A nationwide register-based studyKatarina Glise Sandblad, Sam Schulman, Annika Rosengren, et al.
Thrombosis and Haemostasis|April 21, 2017
NOACs for treatment of venous thromboembolism in clinical practiceSam Schulman, Daniel Singer, Walter Ageno, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2019
Reply: Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in the management of major bleeding: Methodological issuesRahat A Abdoellakhan, Jan Beyer-Westendorf, Sam Schulman, et al.
Thrombosis and Haemostasis|December 23, 2016
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysisAmmar Majeed, Niklas Wallvik, Joakim Eriksson, et al.
Clinical Pharmacology and Therapeutics|May 21, 2005
Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosisMarie Cullberg, Ulf G Eriksson, Karin Wåhlander, et al.
Pageof 31